MetricWire

• Studies that cannot tolerate participant-facing app instability or missing prompts unless the buyer conducts a pilot with their protocol and devices to validate performance.
• Organizations requiring non-U.S. data residency (vendor states U.S. storage on a U.S.-based cloud provider).

Sources: Official vendor privacy & security documentation; user reviews and legacy app feedback.

• Crashes/freezing
• Notification unreliability
• Participant UX friction (buttons, logins)

Source: Chrome-stats mirror of Google Play reviews.

• Competitor material indicates a shift from an older app to Catalyst and suggests some documentation is not publicly posted. Buyers should:
  • confirm which app/version will be used for their studies
  • request current documentation, release notes, and device support matrices

Source: Avicenna "Compared to MetricWire" page.

No public product roadmap with dates was identified in the sources accessed.

• Vendor-published certifications are noted, but public evidence of certificate scope and validity period was not collected here.
• No public penetration test summaries were located in the materials reviewed.

• Vendor statement that MetricWire is "the most published EMA platform" is an unverified claim without a public methodology or bibliometric evidence.
• Any exclusivity claims (for example, statement that MetricWire is the only EMA platform to comply with specific frameworks) should be validated against independent audits and competitor capabilities.

Source: Academic Site Licence page.

Searches did not surface substantive discussions of MetricWire in mainstream tech communities. Results suggest most discourse occurs within academic and clinical research circles rather than public developer forums.

Interpretation: MetricWire has limited visibility in general tech community channels; evidence of usage appears mainly in research publications and institutional guides.

The iOS App Store listing indicates Catalyst is the newer participant experience. The listing indicated insufficient ratings to provide a summary in the captured view. Version history shows frequent "bug fixes" releases, which indicates ongoing maintenance activity.

Source: Official iOS App Store listing.

Because formal B2B review content was not accessible, reasons are inferred from vendor claims and academic adoption signals:

• Vendor states support for regulated research (FDA 21 CFR Part 11, HIPAA, GDPR)
• Platform functionality for EMA/ESM protocols combined with passive data capture
• Academic site license program that supports institutional procurement

Sources: Official vendor documentation; Academic site license information.

From app-store feedback and competitor commentary:

• Participant friction due to app stability and notification reliability can reduce data quality and completion rates.
• Platform/product transition risk: competitor material suggests a shift from an older app to Catalyst and limited public documentation; buyers may have concerns about transparency and change management.

Source: Competitor product comparison page; legacy app review aggregator.

Multiple academic and clinical documents reference using MetricWire/Catalyst in study protocols, indicating adoption in research contexts.

Example: A paper on remote investigation of emerging substances references data collection using "Catalyst by MetricWire."

Source: Peer-reviewed article indexed on PubMed Central.

The Academic Site Licence page contains the vendor statement that "MetricWire is the most published EMA platform." No public methodology, bibliometric analysis, or citation count was provided to support this statement. Treat this as a vendor claim pending independent verification.

Source: Official vendor documentation (Academic Site Licence page).

• No detailed case studies with metrics on impact, ROI, or comparative effectiveness were located on the vendor's website in this research pass.
• No independently verified ROI or impact analyses were found in the publicly available materials reviewed.

• Academic labs to large universities: Often need multi-study capability and standardized governance; site license suggests institutional scale.
• Clinical research organizations (CROs) and digital health teams: Size varies depending on sponsor/CRO requirements.

These ranges are inferred; MetricWire does not publish a formal ICP in the sources reviewed.

• Digital health
• Clinical research
• Behavioral health
• Public health research

Sources: Official vendor documentation; academic usage materials.

• Principal Investigator (PI)
• Study coordinators / research assistants
• Data managers / biostatisticians
• IRB/privacy officers (for compliance review)

• Need for EMA/ESM with contextual triggers and passive sensing
• Acceptance of U.S. data hosting on a U.S.-based cloud provider
• Requirement for vendor-published ISO 27001 / SOC 2 Type II posture (buyers should validate certificate scope and dates)

Primary: Academic and clinical researchers running EMA/ESM protocols and digital health studies (including regulated contexts).

Secondary: Organizations conducting real-world evidence (RWE), patient engagement, or outcomes research in healthcare and behavioral health.

MetricWire offers an Academic Site Licence program oriented toward universities and research institutions.